0000899243-20-025737.txt : 20200918 0000899243-20-025737.hdr.sgml : 20200918 20200918171147 ACCESSION NUMBER: 0000899243-20-025737 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200918 DATE AS OF CHANGE: 20200918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McNeill Jonathan CENTRAL INDEX KEY: 0001824673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201184659 MAIL ADDRESS: STREET 1: C/O DYNE THERAPEUTICS, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-16 0 0001818794 Dyne Therapeutics, Inc. DYN 0001824673 McNeill Jonathan C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 See Remarks Common Stock 2020-09-17 4 A 0 17012 0.00 A 36910 D Stock Option (right to buy) 19.00 2020-09-16 4 A 0 52787 0.00 A 2030-09-15 Common Stock 52787 52787 D Consists of shares of Common Stock issuable under 17,012 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 17, 2021. This option was granted on September 16, 2020. The shares underlying the option are scheduled to vest over four years in equal monthly installments through September 16, 2024. Vice President, Business Development /s/ Richard Scalzo, Attorney-in-Fact 2020-09-18